ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0861

Stem Cell Function and Capsule Tissue Composition Are Associated with Symptoms, Joint Range of Motion and Radiographic Severity in People with Knee Osteoarthritis

T Mark Campbell1, Robert Feibel2, Jeff Dilworth3, Odette Laneuville4 and Guy Trudel5, 1Bruyère Research Institute, Ottawa, ON, Canada, 2The Ottawa Hospital, Ottawa, ON, Canada, 3University of Wisconsin, Madison, WI, 4University of Ottawa, Ottawa, ON, Canada, 5Ottawa Hospital Research Institute, Ottawa, ON, Canada

Meeting: ACR Convergence 2024

Keywords: Mesenchymal stem cells, Osteoarthritis, range of motion

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Abstracts: Osteoarthritis – Novel Insights from Observational Studies

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: Osteoarthritis is a common and debilitating condition without cure. Increased OA severity is associated with lost range of motion (ROM) in the affected joint. Lost ROM may be due to increased fibroblast activity in the joint capsule, leading to fibrous tissue formation1, 2. Fibroblasts are in turn derived from mesenchymal stromal cells (MSCs). To date, a description of capsular MSCs and their association with clinical outcomes is lacking. In this study, we used the Ottawa Knee OA (OKOA) database to test the hypotheses that people with knee OA having a flexion contracture (FC) had increased fibrous tissue and MSC fibrous activity in the posterior capsule. We also analyzed associations between clinically-relevant OA outcomes and histological composition as well as MSC enumeration and differentiation capacity.

Methods: 71 OKOA participants were included (Table 1). Clinical outcomes included maximum knee extension, flexion, radiographic Kellgren and Lawrence (KL) grade, visual analogue (VAS) pain, and Knee Injury and Osteoarthritis Outcome Score (KOOS) scores. Lab-based outcomes included histologic determination of posterior and anterior tissue composition proportions (fibrous, adipose, synovium, other), MSC enumeration (colony-forming unit assay, flow cytometry) and MSC differentiation capacity (fibrogenic, adipogenic, chondrogenic, osteogenic). Associations were first tested with bivariate correlation. Associations with p< 0.10 were further tested using a linear model with generalized estimating equations (GEE), correcting for age, sex, BMI.

Results: No significant differences between FC and no FC groups we discovered. In the posterior capsule, GEE analysis showed associations between the range of knee flexion and MSC adipogenic capacity, MSC osteogenic capacity, KL grade and % other tissue (mainly neurovascular tissue), VAS pain and % fibrous tissue (Table 2). In the anterior capsule, GEE analysis showed associations between the range of knee extension and flow cytometry MSC enumeration, knee flexion, flow cytometry MSC enumeration, KL grade, MSC fibrogenic capacity, MSC chondrogenic capacity and KOOS quality of life (Table 2).          

Conclusion: Joint capsule histology and MSCs were associated with important clinical outcomes of knee OA including knee extension, flexion, KL grade, VAS pain and QoL. These findings suggest that the entire joint capsule, not only the synovium may play important roles in OA-related morbidity and progression and could represent an underappreciated target for OA treatment.

Supporting image 1

Supporting image 2


Disclosures: T. Campbell: None; R. Feibel: None; J. Dilworth: None; O. Laneuville: None; G. Trudel: None.

To cite this abstract in AMA style:

Campbell T, Feibel R, Dilworth J, Laneuville O, Trudel G. Stem Cell Function and Capsule Tissue Composition Are Associated with Symptoms, Joint Range of Motion and Radiographic Severity in People with Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/stem-cell-function-and-capsule-tissue-composition-are-associated-with-symptoms-joint-range-of-motion-and-radiographic-severity-in-people-with-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/stem-cell-function-and-capsule-tissue-composition-are-associated-with-symptoms-joint-range-of-motion-and-radiographic-severity-in-people-with-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology